E-DRUG: Strengthening Regulatory Systems to Improve Medical Product Quality in Low- and Middle-Income Countries
-----------------------------------------------------------------------------------------------
Availability of and access to essential medicines underpins progress against the world's most pressing global health threats. However, these medicines bring about positive outcomes for patients and public health only when are they produced, distributed, and sold in a manner that ensures their quality.
Strengthening Regulatory Systems to Improve Medical Product Quality in Low- and Middle-Income Countries
<https://www.usp-pqm.org/sites/default/files/pqms/article/strengtheningregulatorysystemsforqa_sept2018.pdf>
...is a new publication from the Promoting the Quality of Medicines (PQM) program, which is funded by the U.S. Agency for International Development and implemented by the U.S. Pharmacopeia (USP). This document reviews key regulatory challenges in LMICs, the key areas in which PQM aims to build or strengthen regulatory capacity, and shares lessons learned from the program's extensive implementation experience.
Strengthening the capacity of MRAs requires in-depth and ongoing consideration of the broader country context and health system components that interact and influence MRA operations. As such, PQM relies on strategies and interventions rooted in systems thinking to sustainably strengthen regulatory capacity.
Paul Crystal
USP
Paul Crystal
paul.crystal@USP.org